Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy

American Journal of Roentgenology

Volumn 190, Issue 5, 2008, Pages 1187-1192

  Casciani, Emanuele ^a   Polettini, Elisabetta ^a   Carmenini, Enrico ^b   Floriani, Irene ^c   Masselli, Gabriele ^a   Bertini, Luca ^a   Gualdi, Gian Franco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Ospedale Madre G Vannini   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Contrast enhanced MRI; MRI; Prostate neoplasm; Recurrence

Indexed keywords

GADOLINIUM; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONTROLLED STUDY; ECHOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATECTOMY; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; AGED; COHORT STUDIES; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROSTATECTOMY; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 43649106603     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.07.3032     Document Type: Article

References (28)

1. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999; 281:1591-1597
2. Amling CL, Bergstralh EJ, Blute ML, Slezak JM, Zincke H. Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point? J Urol 2001; 165:1146-1151
3. Rogers R, Grossfeld GD, Roach M III, et al. Radiation therapy for the management of biopsy proved local recurrence after radical prostatectomy. J Urol 1998; 160:1748-1753
4. Bott SR. Management of recurrent disease after radical prostatectomy. Prostate Cancer Prostatic Dis 2004; 7:211-216
5. Lightner DI, Lange PH, Reddy PK, Moore L. Prostate specific antigen and local recurrence after radical prostatectomy. J Urol 1990; 144:921-926
6. Connolly JA, Shinohara K, Presti JC Jr, Carroll PR. Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. Urology 1996; 47:225-231
7. Saleem MD, Sanders H, Abu El Naser M, El-Galley R. Factors predicting cancer detection in biopsy of the prostatic fossa after radical prostatectomy. Urology 1998; 51:283-286
8. Leventis AK, Shariat SF, Slawin KM. Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings. Radiology 2001; 219:432-439
9. Ornstein DK, Colberg JW, Virgo KS, et al. Evaluation and management of men whose radical prostatectomies failed: results of an international survey. Urology 1998; 52:1047-1054
10. Scattoni V, Roscigno M, Raber M, Consonni P, Da Pozzo L, Rigatti P. Biopsy of the vesico-urethral anastomosis after radical prostatectomy: when and how. Eur Urol 2002; 38[suppl 1]:89-95
11. Silverman JM, Krebs TL. MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy. AJR 1997; 168:379-385
12. Sella T, Schwartz LH, Swindle PV, et al. Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. Radiology 2004; 231:379-385
13. Futterer JJ, Engelbrecht MR, Huisman HJ, et al. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology 2005; 237:541-549
14. Futterer JJ, Heijmink S, Scheenen T, et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 2006; 241:449-458
15. Portalez D, Malavaud B, Herigault G, et al. Predicting prostate cancer with dynamic endorectal coil MR and proton spectroscopic MR imaging [in French]. J Radiol 2005; 85[12 Pt 1]:1999-2004
16. Buckley DL, Roberts C, Parker GJ, Logue JP, Hutchinson CE. Prostate cancer: evaluation of vascular characteristics with dynamic contrast enhanced T1-weighted MR imaging-initial experience. Radiology 2004; 233:709-715
17. Lange P, Ercole CI, Lightner DI, Fraley EE, Vessella R. The value of serum prostate specific antigen determinations before and after radical prostatectomy. J Urol 1989; 141:873-879
18. Foster LS, Jajodia P, Fournier G Jr, Shinohara K, Carroll P, Narayan P. The value of prostate specific antigen and transrectal ultrasound guided biopsy in detecting prostatic fossa recurrences following radical prostatectomy. J Urol 1993; 149:1024-1028
19. Scattoni V, Roscigno M, Raber M, et al. Multiple vesico-urethral biopsies following a radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage. Eur Urol 2003; 44:407-414
20. Swindle PW, Kattan MW, Scardino PT. Markers and meaning of primary treatment failure. Urol Clin North Am 2003; 30:377-401
21. John H, Hauri D, Maake C. The effect of seminal vesicle-sparing radical prostatectomy on serum prostate-specific antigen level. BJU Int 2003; 92:920-923
22. Sella T, Schwartz LH, Hricak H. Retained seminal vesicles after radical prostatectomy: frequency, MRI characteristics, and clinical relevance. AJR 2006; 186:539-546
23. Pucar D, Shukla-Dave A, Hricak H, et al. Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience. Radiology 2005; 236:545-553
24. Coakley FV, Teh HS, Qayyum A, et al. Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. Radiology 2004; 233:441-448
25. Mueller-Lisse UG, Vigneron DB, Hricak H, et al. Localized prostate cancer: effect of hormone deprivation therapy measured by using combined three-dimensional 1H MR spectroscopy and MR imaging - clinicopathologic case-controlled study. Radiology 2001; 221:380-390
26. Siegal JA, Yu E, Brawer MK. Topography of neovascularity in human prostate carcinoma. Cancer 1995; 75:2545-2551
27. Brawer MK, Deerings RE, Brown M, Preston SD, Bigler S. Predictors of pathologic stage in prostatic carcinoma: the role of neovascularity. Cancer 1994; 73:678-687
28. Choi YJ, Kim JK, Kim N, et al. Functional MR imaging of prostate cancer. RadioGraphics 2007; 27:63-75